Amphastar Pharmaceuticals (AMPH) Goodwill (2013 - 2026)

Amphastar Pharmaceuticals' Goodwill history runs 14 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• On a quarterly basis, Goodwill rose 5.48% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a 5.48% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 11.58% from the prior year.
• Goodwill retreated to $3.3 million in Q1 2026 per AMPH's latest filing, from $3.4 million in the prior quarter.
• Across five years, Goodwill topped out at $32.3 million in Q3 2023 and bottomed at $2.9 million in Q3 2022.
• The 5-year median for Goodwill is $3.2 million (2023), against an average of $4.9 million.
• Across the five-year window, Goodwill soared 1019.79% in 2023 and plunged 89.92% in 2024, its largest moves.
• Year by year, Goodwill stood at $3.1 million in 2022, then climbed by 2.88% to $3.2 million in 2023, then declined by 5.19% to $3.0 million in 2024, then grew by 11.58% to $3.4 million in 2025, then retreated by 2.12% to $3.3 million in 2026.
• Per Business Quant, the three latest AMPH Goodwill figures stand at $3.3 million (Q1 2026), $3.4 million (Q4 2025), and $3.4 million (Q3 2025).